133 related articles for article (PubMed ID: 21425986)
21. Aberrant rel/nfkb genes and activity in human cancer.
Rayet B; Gélinas C
Oncogene; 1999 Nov; 18(49):6938-47. PubMed ID: 10602468
[TBL] [Abstract][Full Text] [Related]
22. The IKK-NF-kappaB pathway: a source for novel molecular drug targets in pain therapy?
Niederberger E; Geisslinger G
FASEB J; 2008 Oct; 22(10):3432-42. PubMed ID: 18559989
[TBL] [Abstract][Full Text] [Related]
23. NF-κB and the link between inflammation and cancer.
DiDonato JA; Mercurio F; Karin M
Immunol Rev; 2012 Mar; 246(1):379-400. PubMed ID: 22435567
[TBL] [Abstract][Full Text] [Related]
24. Natural and synthetic α,β-unsaturated carbonyls for NF-κB inhibition.
Ramachandran PV; Yip-Schneider M; Schmidt CM
Future Med Chem; 2009 Apr; 1(1):179-200. PubMed ID: 21426075
[TBL] [Abstract][Full Text] [Related]
25. Nuclear transcription factor-kappaB as a target for cancer drug development.
Garg A; Aggarwal BB
Leukemia; 2002 Jun; 16(6):1053-68. PubMed ID: 12040437
[TBL] [Abstract][Full Text] [Related]
26. NF-κB as a potential therapeutic target in microbial diseases.
Vitiello M; Galdiero M; Finamore E; Galdiero S; Galdiero M
Mol Biosyst; 2012 Apr; 8(4):1108-20. PubMed ID: 22311336
[TBL] [Abstract][Full Text] [Related]
27. NF-kappaB signalling: embracing complexity to achieve translation.
Chakraborty JB; Mann DA
J Hepatol; 2010 Feb; 52(2):285-91. PubMed ID: 20022129
[TBL] [Abstract][Full Text] [Related]
28. Potential pharmacological control of the NF-κB pathway.
Sethi G; Tergaonkar V
Trends Pharmacol Sci; 2009 Jun; 30(6):313-21. PubMed ID: 19446347
[TBL] [Abstract][Full Text] [Related]
29. Modulation of NF-κB Signaling as a Therapeutic Target in Autoimmunity.
Herrington FD; Carmody RJ; Goodyear CS
J Biomol Screen; 2016 Mar; 21(3):223-42. PubMed ID: 26597958
[TBL] [Abstract][Full Text] [Related]
30. Identification and functional characterization of SIMPL in Crassostrea gigas reveals its ancient origin and involvement in the regulation of Rel/NF-κB transcription activity.
Zhang Y; Li J; Yu F; Tong Y; Zhang Y; Xiang Z; Yu Z
Fish Shellfish Immunol; 2014 Sep; 40(1):239-44. PubMed ID: 25038279
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of NF-κB signaling as a strategy in disease therapy.
Gilmore TD; Garbati MR
Curr Top Microbiol Immunol; 2011; 349():245-63. PubMed ID: 21113699
[TBL] [Abstract][Full Text] [Related]
32. The nuclear factor--kappa B pathway in atherosclerosis: a potential therapeutic target for atherothrombotic vascular disease.
Pamukcu B; Lip GY; Shantsila E
Thromb Res; 2011 Aug; 128(2):117-23. PubMed ID: 21636112
[TBL] [Abstract][Full Text] [Related]
33. Co-imaging of RelA and c-Rel reveals features of NF-κB signaling for ligand discrimination.
Rahman SMT; Singh A; Lowe S; Aqdas M; Jiang K; Vaidehi Narayanan H; Hoffmann A; Sung MH
Cell Rep; 2024 Mar; 43(3):113940. PubMed ID: 38483906
[TBL] [Abstract][Full Text] [Related]
34. Rel/NF-κB Transcription Factors Emerged at the Onset of Opisthokonts.
Leger MM; Ros-Rocher N; Najle SR; Ruiz-Trillo I
Genome Biol Evol; 2022 Jan; 14(1):. PubMed ID: 34999783
[TBL] [Abstract][Full Text] [Related]
35. NF-kappaB inhibitors for the treatment of inflammatory diseases and cancer.
Calzado MA; Bacher S; Schmitz ML
Curr Med Chem; 2007; 14(3):367-76. PubMed ID: 17305539
[TBL] [Abstract][Full Text] [Related]
36. Targeting IKK and NF-κB for Therapy.
Durand JK; Baldwin AS
Adv Protein Chem Struct Biol; 2017; 107():77-115. PubMed ID: 28215229
[TBL] [Abstract][Full Text] [Related]
37. Does resveratrol inhibit NF-kappaB activity?
Braeuning A
Pharmazie; 2014 Jan; 69(1):54. PubMed ID: 24601224
[No Abstract] [Full Text] [Related]
38. NF-κB subunits direct kinetically distinct transcriptional cascades in antigen receptor-activated B cells.
Zhao M; Chauhan P; Sherman CA; Singh A; Kaileh M; Mazan-Mamczarz K; Ji H; Joy J; Nandi S; De S; Zhang Y; Fan J; Becker KG; Loke P; Zhou W; Sen R
Nat Immunol; 2023 Sep; 24(9):1552-1564. PubMed ID: 37524800
[TBL] [Abstract][Full Text] [Related]
39. NF-kappaB in human disease: current inhibitors and prospects for de novo structure based design of inhibitors.
Pande V; Ramos MJ
Curr Med Chem; 2005; 12(3):357-74. PubMed ID: 15723624
[TBL] [Abstract][Full Text] [Related]
40. Novel Anthra[1,2-c][1,2,5]Thiadiazole-6,11-Diones as Promising Anticancer Lead Compounds: Biological Evaluation, Characterization & Molecular Targets Determination.
Ali AA; Lee YR; Chen TC; Chen CL; Lee CC; Shiau CY; Chiang CH; Huang HS
PLoS One; 2016; 11(4):e0154278. PubMed ID: 27100886
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
